These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pancreatic Cancer Complicated by Pancreatitis Demonstrated on FDG PET/CT. Hennessy G; Vamadevan S; Loh H; Bui C; Le K; Mansberg R Clin Nucl Med; 2017 Mar; 42(3):239-240. PubMed ID: 28098664 [TBL] [Abstract][Full Text] [Related]
4. Role of 18F-FDG PET/CT in the management of a case of autoimmune pancreatitis with extrapancreatic manifestations. Santhosh S; Bhattacharya A; Harisankar CN; Kochhar R; Mittal BR Clin Nucl Med; 2013 Nov; 38(11):e423-5. PubMed ID: 23510878 [TBL] [Abstract][Full Text] [Related]
5. Imaging diagnosis of post-ERCP focal pancreatitis mimicking pancreatic carcinoma by follow-up F-18 FDG PET/CT. Jeong Yoon S; Lee B; Park CH Clin Nucl Med; 2011 Jan; 36(1):70-2. PubMed ID: 21157219 [TBL] [Abstract][Full Text] [Related]
6. Pancreatic Mass in a Patient With an Increased Serum Level of IgG4. Matsumori T; Shiokawa M; Kodama Y Gastroenterology; 2018 Aug; 155(2):269-270. PubMed ID: 29410043 [No Abstract] [Full Text] [Related]
7. Utility of 18F-FDG PET/CT for differentiation of autoimmune pancreatitis with atypical pancreatic imaging findings from pancreatic cancer. Lee TY; Kim MH; Park DH; Seo DW; Lee SK; Kim JS; Lee KT AJR Am J Roentgenol; 2009 Aug; 193(2):343-8. PubMed ID: 19620430 [TBL] [Abstract][Full Text] [Related]
8. Clinical Utility of FDG PET/CT in Patients with Autoimmune Pancreatitis: a Case-Control Study. Cheng MF; Guo YL; Yen RF; Chen YC; Ko CL; Tien YW; Liao WC; Liu CJ; Wu YW; Wang HP Sci Rep; 2018 Feb; 8(1):3651. PubMed ID: 29483544 [TBL] [Abstract][Full Text] [Related]
9. [Differentiation of autoimmune pancreatitis and pancreatic ductal adenocarcinoma based on multi-modality texture features in Zhang Y; Cheng C; Liu Z; Pan G; Sun G; Yang X; Zuo C Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2019 Oct; 36(5):755-762. PubMed ID: 31631623 [TBL] [Abstract][Full Text] [Related]
10. Is (18)F-fluorodeoxyglucose positron emission tomography meaningful for estimating the efficacy of corticosteroid therapy in patients with autoimmune pancreatitis? Shigekawa M; Yamao K; Sawaki A; Hara K; Takagi T; Bhatia V; Nishio M; Tamaki T; El-Amin H; Sayed Zel-A; Mizuno N J Hepatobiliary Pancreat Sci; 2010 May; 17(3):269-74. PubMed ID: 19727541 [TBL] [Abstract][Full Text] [Related]
11. Localized autoimmune pancreatitis mimicking pancreatic cancer: Case report and literature review. Hsu WL; Chang SM; Wu PY; Chang CC J Int Med Res; 2018 Apr; 46(4):1657-1665. PubMed ID: 29332510 [TBL] [Abstract][Full Text] [Related]
12. Usefulness of positron emission tomography in the evaluation of distribution and activity of systemic lesions associated with autoimmune pancreatitis. Matsubayashi H; Furukawa H; Maeda A; Matsunaga K; Kanemoto H; Uesaka K; Fukutomi A; Ono H Pancreatology; 2009; 9(5):694-9. PubMed ID: 19684434 [TBL] [Abstract][Full Text] [Related]
13. Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography. Ozaki Y; Oguchi K; Hamano H; Arakura N; Muraki T; Kiyosawa K; Momose M; Kadoya M; Miyata K; Aizawa T; Kawa S J Gastroenterol; 2008; 43(2):144-51. PubMed ID: 18306988 [TBL] [Abstract][Full Text] [Related]
14. Focal Immunotherapy-Induced Pancreatitis Mimicking Metastasis on FDG PET/CT. Das JP; Halpenny D; Do RK; Ulaner GA Clin Nucl Med; 2019 Oct; 44(10):836-837. PubMed ID: 31283599 [TBL] [Abstract][Full Text] [Related]
15. Autoimmune pancreatitis: whole-body 18F-FDG PET/CT findings. Zhang J; Shao C; Wang J; Cheng C; Zuo C; Sun G; Cui B; Dong A; Liu Q; Kong L Abdom Imaging; 2013 Jun; 38(3):543-9. PubMed ID: 23223832 [TBL] [Abstract][Full Text] [Related]
16. Autoimmune pancreatitis: differentiation from pancreatic carcinoma and normal pancreas on the basis of enhancement characteristics at dual-phase CT. Takahashi N; Fletcher JG; Hough DM; Fidler JL; Kawashima A; Mandrekar JN; Chari ST AJR Am J Roentgenol; 2009 Aug; 193(2):479-84. PubMed ID: 19620446 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose for the differentiation of chronic pancreatitis and pancreatic cancer. Imdahl A; Nitzsche E; Krautmann F; Högerle S; Boos S; Einert A; Sontheimer J; Farthmann EH Br J Surg; 1999 Feb; 86(2):194-9. PubMed ID: 10100786 [TBL] [Abstract][Full Text] [Related]
18. [Autoimmune pancreatitis is a differential diagnosis to pancreatic cancer]. Rode AA; Bremholm L Ugeskr Laeger; 2014 Oct; 176(44):. PubMed ID: 25354007 [TBL] [Abstract][Full Text] [Related]
19. [Fluorodeoxyglucose positron emission tomography (FDG-PET) in the differential diagnosis of pancreatic lesions]. Zimny M; Schumpelick V Chirurg; 2001 Sep; 72(9):989-94. PubMed ID: 11594284 [TBL] [Abstract][Full Text] [Related]
20. Utility of FDG-PET/CT in the diagnosis of IgG4-related diseases. Zhao Z; Wang Y; Guan Z; Jin J; Huang F; Zhu J Clin Exp Rheumatol; 2016; 34(1):119-25. PubMed ID: 26842851 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]